ORT B Share Price | Ortoma AB Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Flat results in Sep 25

RAW MATERIAL COST(Y) Grown by 7,066.67% (YoY)
NET SALES(Q) Lowest at SEK 2.43 MM
OPERATING PROFIT(Q) Lowest at SEK -11.24 MM

Risky -

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

SEK 374 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.15

Return on Equity

-13.42%

Price to Book

2.62

Revenue and Profits:

Net Sales:

5 Million

(Quarterly Results - Dec 2025)

Net Profit:

-22 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-30.04%

6 Months

-36.47%

1 Year

6.26%

2 Years

-2.29%

3 Years

32.2%

4 Years

0.0%

5 Years

0.0%

Ortoma AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

139.13%

EBIT Growth (5y)

5.79%

EBIT to Interest (avg)

-5.64

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.17

Sales to Capital Employed (avg)

0.33

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

1.35%

ROE (avg)

1.30%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.76

EV to EBIT

-39.01

EV to EBITDA

40.04

EV to Capital Employed

1.99

EV to Sales

3.26

PEG Ratio

Dividend Yield

ROCE (Latest)

-5.10%

ROE (Latest)

-4.54%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

Bullish

Bearish

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -72.83% vs 10.90% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -111.43% vs 63.41% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.70",
          "val2": "17.30",
          "chgp": "-72.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-17.10",
          "val2": "-8.40",
          "chgp": "-103.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-22.20",
          "val2": "-10.50",
          "chgp": "-111.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4,740.30%",
          "val2": "-663.90%",
          "chgp": "-407.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 31.57% vs 28.87% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -65.52% vs 47.03% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "64.60",
          "val2": "49.10",
          "chgp": "31.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.50",
          "val2": "-1.50",
          "chgp": "-66.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-19.20",
          "val2": "-11.60",
          "chgp": "-65.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-267.80%",
          "val2": "-279.00%",
          "chgp": "1.12%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

4.70

17.30

-72.83%

Operating Profit (PBDIT) excl Other Income

-17.10

-8.40

-103.57%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-22.20

-10.50

-111.43%

Operating Profit Margin (Excl OI)

-4,740.30%

-663.90%

-407.64%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is -72.83% vs 10.90% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -111.43% vs 63.41% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

64.60

49.10

31.57%

Operating Profit (PBDIT) excl Other Income

-2.50

-1.50

-66.67%

Interest

0.00

Exceptional Items

-0.00

0.00

Consolidate Net Profit

-19.20

-11.60

-65.52%

Operating Profit Margin (Excl OI)

-267.80%

-279.00%

1.12%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 31.57% vs 28.87% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -65.52% vs 47.03% in Dec 2024

All Annual Results

Company CV

About Ortoma AB

Ortoma AB

Hospital

Ortoma AB is a Sweden-based company engaged in the medical technology. It develops an operation system for planning and positioning of joint implants in hip, knee and back surgery. The Company’s portfolio of products include Ortoma Treatment Solution, an integrated planning and measuring system, including a camera, navigation equipment and three-dimensional (3D) graphics for planning and performing prosthetic operations; Ortoma Plan, a preoperative planning system which allows surgeons to measure patient’s anatomy based on computer tomography or magnetic resonance, view it in 3D and plan operation and choice of implant before surgery; and Ortoma Guide, a navigation device which allows precise measurement and positioning of implants during operations. The Company cooperates with orthopedic departments at Sahlgrenska University Hospital, Skane University Hospital and Gothenburg University.

Company Coordinates

Company Details

Falkenbergsgatan 3 8Tr , GOETEBORG None : 412 85

Tel: 46 31 7735163

http://www.ortoma.com

Registrar Details